Evidence map›Paper›PMID 37198712›Full record

SynthesisGenome biology2023

Meta-analysis of (single-cell method) benchmarks reveals the need for extensibility and interoperability.

Anthony Sonrel, Almut Luetge, Charlotte Soneson, Izaskun Mallona, Pierre-Luc Germain, Sergey Knyazev, Jeroen Gilis, Reto Gerber, Ruth Seurinck, Dominique Paul and 10 more

Abstract readMeta-AnalysisLetter
In one paragraph

Synthesis in Genome biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Anthony Sonrel *Department of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
Almut Luetge *Department of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
Charlotte Soneson *SIB Swiss Institute of Bioinformatics, Zurich, Switzerland.
Izaskun Mallona *Department of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
Pierre-Luc Germain *Department of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
Sergey KnyazevDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Jeroen GilisDepartment of Applied Mathematics, Computer Science & Statistics, Ghent University, Ghent, Belgium.
Reto GerberDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
Ruth SeurinckDepartment of Applied Mathematics, Computer Science & Statistics, Ghent University, Ghent, Belgium.
Dominique PaulDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
Emanuel SonderDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
Helena L CrowellDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
Imran FanaswalaDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
Ahmad Al-AjamiDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
Elyas HeidariDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
Stephan SchmeingDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
Stefan MilosavljevicDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
Yvan SaeysDepartment of Applied Mathematics, Computer Science & Statistics, Ghent University, Ghent, Belgium.
Serghei MangulDepartment of Clinical Pharmacy, School of Pharmacy, University of Southern California, Los Angeles, CA, USA.
Mark D RobinsonDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland. mark.robinson@mls.uzh.ch.ORCID 0000-0002-3048-5518

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Computational methods represent the lifeblood of modern molecular biology. Benchmarking is important for all methods, but with a focus here on computational methods, benchmarking is critical to dissect important steps of analysis pipelines, formally assess performance across common situations as well as edge cases, and ultimately guide users on what tools to use. Benchmarking can also be important for community building and advancing methods in a principled way. We conducted a meta-analysis of recent single-cell benchmarks to summarize the scope, extensibility, and neutrality, as well as technical features and whether best practices in open data and reproducible research were followed. The results highlight that while benchmarks often make code available and are in principle reproducible, they remain difficult to extend, for example, as new methods and new ways to assess methods emerge. In addition, embracing containerization and workflow systems would enhance reusability of intermediate benchmarking results, thus also driving wider adoption.

Indexed as

Computational BiologyWorkflow

Identifiers

PMID37198712
PMCPMC10189979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.